BCL2 and B-cell chronic lymphocytic leukemia: Mechanisms of resistance have been elucidated most clearly in the setting of CLL, where mutations in BCL2, overexpression of pro-survival proteins MCL1 and BCLxL and aberrancy in other essential pathways, such as growth signalling, cell cycling and epigenetic regulation have been demonstrated [66].